Ocular Therapeutix Gross Profit vs. Profit Margin

OCUL Stock  USD 9.35  0.09  0.95%   
Based on the key profitability measurements obtained from Ocular Therapeutix's financial statements, Ocular Therapeutix may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Ocular Therapeutix's ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
2012-12-31
Previous Quarter
14.9 M
Current Value
13.9 M
Quarterly Volatility
5.6 M
 
Yuan Drop
 
Covid
At this time, Ocular Therapeutix's Days Sales Outstanding is quite stable compared to the past year. Days Of Sales Outstanding is expected to rise to 293.54 this year, although the value of Price To Sales Ratio will most likely fall to 5.79. At this time, Ocular Therapeutix's Net Income Per E B T is quite stable compared to the past year.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.610.9096
Way Down
Slightly volatile
For Ocular Therapeutix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ocular Therapeutix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ocular Therapeutix utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ocular Therapeutix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ocular Therapeutix over time as well as its relative position and ranking within its peers.
  

Ocular Therapeutix's Revenue Breakdown by Earning Segment

Check out Your Equity Center.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Revenue Per Share
0.529
Quarterly Revenue Growth
0.083
Return On Assets
(0.22)
Return On Equity
(0.73)
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ocular Therapeutix Profit Margin vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ocular Therapeutix's current stock value. Our valuation model uses many indicators to compare Ocular Therapeutix value to that of its competitors to determine the firm's financial worth.
Ocular Therapeutix is regarded fifth in gross profit category among its peers. It is rated below average in profit margin category among its peers . At this time, Ocular Therapeutix's Gross Profit is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ocular Therapeutix by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ocular Profit Margin vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Ocular Therapeutix

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
(6.51 M)
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Ocular Therapeutix

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(2.26) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.

Ocular Profit Margin Comparison

Ocular Therapeutix is currently under evaluation in profit margin category among its peers.

Ocular Therapeutix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Ocular Therapeutix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ocular Therapeutix will eventually generate negative long term returns. The profitability progress is the general direction of Ocular Therapeutix's change in net profit over the period of time. It can combine multiple indicators of Ocular Therapeutix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-9 M-8.6 M
Operating Income-82.4 M-86.5 M
Income Before Tax-80.7 M-84.8 M
Total Other Income Expense Net1.6 M1.7 M
Net Loss-80.7 M-84.8 M
Income Tax Expense2.8 MM
Net Loss-67.1 M-70.4 M
Non Operating Income Net Other16.8 M17.7 M
Net Loss-63.9 M-67.1 M
Interest Income2.9 M3.1 M
Net Interest Income-6.1 M-6.4 M
Change To Netincome2.8 M2.7 M
Net Loss(1.01)(1.06)
Income Quality 0.87  1.25 
Net Income Per E B T 0.80  0.89 

Ocular Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ocular Therapeutix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ocular Therapeutix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ocular Therapeutix's important profitability drivers and their relationship over time.

Use Ocular Therapeutix in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocular Therapeutix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocular Therapeutix will appreciate offsetting losses from the drop in the long position's value.

Ocular Therapeutix Pair Trading

Ocular Therapeutix Pair Trading Analysis

The ability to find closely correlated positions to Ocular Therapeutix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocular Therapeutix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocular Therapeutix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocular Therapeutix to buy it.
The correlation of Ocular Therapeutix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocular Therapeutix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocular Therapeutix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocular Therapeutix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Ocular Therapeutix position

In addition to having Ocular Therapeutix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hotels Thematic Idea Now

Hotels
Hotels Theme
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Ocular Therapeutix is a strong investment it is important to analyze Ocular Therapeutix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocular Therapeutix's future performance. For an informed investment choice regarding Ocular Stock, refer to the following important reports:
Check out Your Equity Center.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
To fully project Ocular Therapeutix's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ocular Therapeutix at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ocular Therapeutix's income statement, its balance sheet, and the statement of cash flows.
Potential Ocular Therapeutix investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Ocular Therapeutix investors may work on each financial statement separately, they are all related. The changes in Ocular Therapeutix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ocular Therapeutix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.